Maze Therapeutics (MAZE) Other Non Operating Income (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Other Non Operating Income data on file, last reported at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 10.33% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 266.32% YoY), and the FY2025 full-year result was $85000.0, up 100.96% from the prior year.
• Other Non Operating Income improved to $2.3 million in Q1 2026, from $85000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.6 million in Q1 2025 to a low of -$4.8 million in Q1 2024.
• A 3-year average of -$541714.3 and a median of $85000.0 in 2025 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income jumped 154.93% in 2025 and fell 10.33% in 2026, its largest moves.
• Tracing MAZE's Other Non Operating Income over 3 years: stood at -$1.6 million in 2024, then jumped by 105.17% to $85000.0 in 2025, then soared by 2658.82% to $2.3 million in 2026.
• Business Quant data shows MAZE's Other Non Operating Income at $2.3 million in Q1 2026, $85000.0 in Q4 2025, and $2.6 million in Q1 2025.